Victory Capital Management Inc 4 D Molecular Therapeutics, Inc. Transaction History

Victory Capital Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$6.96 - $11.48 $5,289 - $8,724	-760 Reduced 6.45%	11,018 $89,000
Q2 2022 Aug 01, 2022	SELL	$5.68 - $15.99 $39 - $111	-7 Reduced 0.06%	11,778 $82,000
Q1 2022 May 04, 2022	SELL	$13.16 - $22.64 $5,171 - $8,897	-393 Reduced 3.23%	11,785 $140,000
Q4 2021 Feb 07, 2022	SELL	$19.56 - $32.94 $1,584 - $2,668	-81 Reduced 0.66%	12,178 $267,000
Q3 2021 Nov 02, 2021	SELL	$22.73 - $36.04 $2,977 - $4,721	-131 Reduced 1.06%	12,259 $331,000

Q2 2021 Aug 03, 2021	SELL	$22.2 - $42.29 $5,616 - $10,699	-253 Reduced 2.0%	12,390 $298,000
Q1 2021 May 04, 2021	BUY	$35.94 - $52.67 $94,989 - $139,206	2,643 Added 26.43%	12,643 $548,000
Q4 2020 Feb 01, 2021	BUY	$38.43 - $47.36 $384,300 - $473,600	10,000 New	10,000 $415,000

157

50.3M

718K

370K

Ticker FDMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,382,400
Market Cap $675M
Description
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.